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Available online 14 May 2016Background: Pulse wave velocity (PWV) is a noninvasive technique to evaluate arterial stiffness, a dynamic
property of the vessels, reﬂecting their structure and function. Childhood obesity is associated with several
cardiovascular comorbidities and to the progression of atherosclerosis. We aimed to compare carotid-femoral
PWV between normal weight and overweight/obese prepubertal children and to quantify its association with
other cardiovascular risk factors.
Methods: Cross-sectional study of 315 children aged 8–9 years. Anthropometrics, 24-h ambulatory blood
pressure (BP) and carotid-femoral PWVwere measured. Classiﬁcation of obesity was according toWorld Health
Organization (WHO) body mass index (BMI)-for-age reference values.
Results: Compared to normal weight children, overweight and obese children presented signiﬁcantly higher
levels of PWV (4.95 (P25–P75: 4.61–5.23), 5.00 (4.71–5.33), 5.10 (4.82–5.50) m/s, respectively; ptrend b 0.001).
Signiﬁcant positive correlations were found between PWV and total cholesterol, LDL cholesterol, triglycerides,
fasting insulin and insulin resistance levels (HOMA-IR) and with high-sensitivity C-reactive protein (hs-CRP).
In a multivariate linear regression model adjusted for sex, age, height and 24-h systolic blood pressure z-score,
the independent determinants of PWV were BMI, HOMA-IR and the absence of dipping.
Conclusions: The association between PWV and the loss of dipping and insulin resistance levels, independently of
the BMI, reinforces the contribution of these comorbidities to vascular injury in early life.
© 2016 Elsevier Ireland Ltd. All rights reserved.Keywords:
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Obesity is a prominent public health problem worldwide with a
growing prevalence in both adults and children [1]. Childhood obesity
is known to be associated with the premature development of several
cardiovascular (CV) risk factors, such as dyslipidemia, hypertension
and insulin resistance [2], and with the development and progression
of atherosclerosis [3]. In fact, the process of atherosclerosis, a common
denominator in CV diseases, was demonstrated to begin in early life,
with preclinical vascular wall abnormalities being already present in
childhood [4,5].l aspects of the reliability and
ed interpretation.
UniversidadedoPorto (ISPUP),
.Arterial stiffness is a dynamic property of the vessels which reﬂects
changes in the arterial structure and function [6]. In adults, several
promising techniques for large arterial function evaluation continue to
emerge, such as wave intensity analysis [7,8]. Arterial stiffness is an
indirect marker of subclinical atherosclerosis [6] that has proved to be
an accurate CV risk predictor in adults [9]. In the pediatric population
its usefulness is also being increasingly recognized [6]. Pulse wave
velocity (PWV) can be used to assess arterial stiffness by a noninvasive
and high-resolution technique [10] that has become one of the primary
methods for evaluation of vascular damage in childhood [6,11]. PWV,
the pulse pressure's velocity during its propagation along the arterial
tree [12], depends on geometric and elastic properties of the arterial
wall [11] and is inﬂuencedby various factors such as age, height, gender,
race and blood pressure [11,13,14].
Several CV risk factors can accelerate the age-related natural process
of atherogenesis [12,15]. Speciﬁcally in children some studies reported
lower values of PWV in the obese [16,17], but the overall evidence is
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and PWV compared to non-obese controls [18]. At the same time, con-
tradictory evidence still exists concerning the relationship between
pulse wave velocity and classical CV risk factors, such as dyslipidemia
[19–21]. Higher levels of blood pressure (BP) are usually positively
associated with parameters of arterial stiffness [13,14,16] and the asso-
ciation of the latter with insulin resistance levels has also been reported
[22]. The differentiation between the natural process of vessels' devel-
opment and aging from the pathological inﬂuence of CV risk factors
on the vascular tree is quite challenging, particularly during child's
growth [23]. For this reason, we consider particularly important to
evaluate the association of PWV values with obesity and CV risk factors
in young children, avoiding the issue of secondary pathology related to
target-organ damage and comorbidities often encountered in older
populations.
Our main objective was to compare carotid-femoral PWV between
normalweight andoverweight/obese 8–9-year-old children. Secondarily,
we aimed to identify if an association between other cardiovascular risk
factors and pulse wave velocity could be found.
2. Methods
2.1. Study design and sample
We studied children aged 8–9 years that have been followed
since birth in a previously established cohort study (Generation XXI,
Porto-Portugal) [24]. From the original cohort (n = 8647), 4590
children attended a face-to-face follow-up visit at 7 years, thus being
eligible for the ObiKid project — a speciﬁc project aiming to clarify the
impact of childhood obesity and associated comorbidities on the kidney.
To obtain a minimum sample of 300 children for the ObiKid project,
we consecutively screened 463 children, according to the date of
their 7 years old evaluation: 16 could not be contacted, 32 refused to
participate, 23 unable to schedule the study visit during the recruitment
period and 68met exclusion criteria (4 chronic diseases, 1 chronic usage
of medication, 51 with residence N30 km away from the study site and
6 pairs of twins). We enrolled 324 participants, between August 2013
and August 2014, but for the present analysis we additionally excluded
9 children due to incomplete evaluation, such as absence of PWV
assessment.
A total of 315 children were included, which provides a statistical
power above 95% to detect a difference in PWV levels between
nonoverweight and overweight/obese children of at least 1.2 m/s
(assuming a standard deviation (SD) of 1.0 in each group) [25].
2.2. Data collection and variables deﬁnition
The study visits took place at theDepartment of Clinical Epidemiology,
Predictive Medicine and Public Health, Faculty of Medicine of University
of Porto. Anthropometric and general physical examination were
performed, according to standard procedures and as previously reported
[26]. Waist circumference was indexed to height (waist-to-height ratio,
WHtR in cm/m) for statistical analysis. Body mass index (BMI) was
calculated and BMI-for-age values were classiﬁed according to the
World Health Organization (WHO) reference data for BMI z-score into
the following categories: nonoverweight (≤+ 1 SD, including 1 children
with thinness) and overweight/obesity (N+1 SD) [27]. Body fat percent-
age was assessed by foot-to-foot bioelectrical impedance analysis
(Tanita®, model TBF-300, Arlington Heights, Illinois).
Ambulatory BP monitoring (ABPM) for 24 h was performed
with a portable non-invasive oscillometric BP recorder (Spacelabs
Healthcare®, model 90,207, Snoqualmie, Washington). The non-
dominant arm was used in all children with a cuff size appropriate to
the child's arm circumference. BP measurements were taken automati-
cally at 20-min intervals during the daytime and at 30-min intervals
during the nighttime. A minimum monitoring duration of 24 h withgaps of less than 2 hwas required for acceptance; 5 examswere exclud-
ed of the ABPM analysis due to insufﬁcient readings. The readings were
used to calculate mean 24 h, day and night mean arterial pressure
(MAP), systolic (SBP) and diastolic BP (DBP), with the SpaceLabs®
software. Standard deviation scores for BP values were calculated (by
the least mean square method) and hypertension was deﬁned using
the published reference values of the German Working Group on
Pediatric Hypertension [28]. The absence of dipping was considered as
a fall in theMAP during nighttime of less than 10% of the corresponding
daytime MAP.
The carotid-femoral PWV analysis was performed by a single
trained cardiopneumology technician with a portable device
(Micro Medical®, model PulseTrace PWV PT4000, Kent, UK).
Children were placed in a supine position. After 5 min of rest, the
carotid-femoral distance was assessed as the distance of suprasternal
notch to the umbilicus and from there to the measuring point
at the femoral artery minus the suprasternal notch to the measuring
point at the carotid artery. Electrocardiogram registry was per-
formed simultaneously, allowing the software to calculate the time
from the peak of the R-wave to the foot of the pulse wave at the ca-
rotid and femoral arteries, respectively. The digital volume pulse
waveform had to ﬁll 2/3 of the display with little or no noise and ar-
tifact to be considered and 3 measurements of PWV were performed
and averaged for analysis.2.3. Laboratory procedures
A venous blood sample was collected from all the participants,
after an overnight fast of at least 8 h and analyzed for glucose, insulin,
triglycerides, total cholesterol, high-density lipoprotein cholesterol
and low-density lipoprotein cholesterol, high-sensitivity C-reactive
protein (hsCRP) and interleukin-6 (IL-6). Insulin resistance was deter-
mined using the homeostasis model assessment index (HOMA-IR).
All the standard laboratory analyses were performed in the Clinical
Pathology Department of Centro Hospitalar São João, Porto — Portugal.
hsCRP was tested by immunonephelometric assay with CardioPhase®
hsCRP (Siemens Healthcare Diagnostics®, Munich, Germany) and IL-6
was tested by immunoassay (Cobas Integra 700 Autoanalyzer,
Roche®, Basel, Switzerland).2.4. Ethics
The ObiKid study was approved by the Ethics Committee of Centro
Hospitalar São João, Porto – Portugal and Faculty of Medicine of the
University of Porto and by the Portuguese Data Protection Authority.
It complies with the Helsinki Declaration and the current national legis-
lation.Written informed consent fromparents (or their legal substitute)
and verbal assent from children was obtained regarding the collection
of information and biological samples.2.5. Statistical analysis
Data are presented as mean and standard-deviation (SD) or, if
skewed, as median and percentiles 25 and 75 (P25-P75). The tertiles
of WHtR and % of body fat mass were deﬁned based on all enrolled
participants. Bivariate associations were assessed by Spearman correla-
tion. A multivariate linear regression model was ﬁtted to identify inde-
pendent determinants of carotid-femoral PWV. Sex, age (in months),
height (in cm) and 24-h systolic BP, factors known to affect PWV [11,
13,14], were forced into the model. Additionally, all variables with
signiﬁcant correlations were initially included in the linear regression
model as covariates and a backward stepwise approach was performed
to ﬁt the ﬁnal model.
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A total of 315 children (53%male) with a mean (SD) age of 8.8 (0.2)
years were included in the present analysis. General characteristics,
ABPM values and laboratorial parameters are shown in Table 1, by
classes of BMI (normal weight, n = 165; overweight, n = 89; obese,
n= 61). Regarding ABPM values, a trend towards higher z-score values
across BMI classes was evident for 24-h, daytime and nighttime systolic
BP. No differences were found between the groups in the diastolic
BP z-score values, percentage of children presenting hypertension
and non-dipping pattern. Overweight and obese children presented
signiﬁcantly higher levels of triglycerides, fasting insulin and HOMA-IR
and hs-CRP.Table 1
Characteristics and laboratorial parameters, in non-overweight, overweight and obese
children.
WHO BMI z-score classiﬁcation p
Normal weight Overweight Obese
n = 165 n = 89 N = 61
Demography and anthropometry
Age (months) 105.0 ± 2.9 105.3 ± 2.8 105.6 ± 2.8 0.394
Male sex 84 (50.9%) 43 (48.3%) 40 (65.6%) 0.084
BMI z-score −0.01 ± 0.74 1.56 ± 0.30 2.70 ± 0.5 b0.001
WHtR (cm/m) 44.8 ± 2.5 50.2 ± 3.3 56.6 ± 4.5 b0.001
% body fat mass 11.0 ± 7.2 20.1 ± 7.9 28.0 ± 9.4 b0.001
24-h ambulatory blood pressure
24-h systolic
BP (mm Hg)
111.6 ± 7.0 113.2 ± 7.2 114.5 ± 8.8 0.026
z-Score 0.48 ± 0.97 0.93 ± 0.99 0.78 ± 0.98 0.002
24-h diastolic
BP (mm Hg)
67.0 ± 4.4 67.1 ± 5.2 66.5 ± 6.0 0.783
z-Score 0.06 ± 0.94 0.29 ± 1.05 0.06 ± 1.10 0.204
Daytime systolic
BP (mm Hg)
115.7 ± 7.3 116.9 ± 7.9 118.2 ± 9.0 0.083
z-Score 0.35 ± 1.01 0.72 ± 1.04 0.57 ± 1.14 0.023
Daytime diastolic
BP (mm Hg)
71.1 ± 4.6 70.6 ± 5.6 70.0 ± 6.3 0.387
z-Score −0.26 ± 0.88 −0.14 ± 0.92 −0.31 ± 1.06 0.456
Nighttime systolic
BP (mm Hg)
102.9 ± 6.9 104.8 ± 6.6 106.0 ± 8.6 0.007
z-Score 0.54 ± 0.93 0.99 ± 0.84 0.87 ± 0.73 b0.001
Nighttime diastolic
BP (mm Hg)
58.4 ± 5.2 58.7 ± 5.7 58.7 ± 6.0 0.884
z-Score 0.23 ± 0.98 0.42 ± 0.97 0.24 ± 0.99 0.319
Hypertension 12 (7.5%) 8 (9.0%) 10 (16.7%) 0.116
Absence of dipping
pattern (mm Hg)
35 (21.7%) 30 (33.7%) 17 (28.3%) 0.113
Laboratorial parameters
Total cholesterol
(mg/dL)
156.5 ± 24.7 162.7 ± 28.1 161.7 ± 24.7 0.131
LDL cholesterol
(mg/dL)
91.7 ± 19.9 96.5 ± 23.1 95.9 ± 21.9 0.157
HDL cholesterol
(mg/dL)
54.8 ± 10.1 53.7 ± 10.4 51.9 ± 8.5 0.150
Triglycerides
(mg/dL)
53.1 ± 19.6 62.1 ± 29.8 69.3 ± 32.8 b0.001
Fasting glucose
(mg/dL)
85.7 ± 5.5 85.4 ± 5.3 87.3 ± 5.0 0.078
Fasting insulin
(μIU/mL)
5.7 ± 2.4 7.2 ± 2.9 9.5 ± 5.1 b0.001
HOMA-IR 1.12
(0.83–1.96)
1.46
(1.07–1.84)
1.68
(1.30–2.63)
b0.001
High sensitivity
C-reactive
protein (mg/L)
0.0 (0.0–0.40) 0.50
(0.20–1.18)
0.70
(0.35–1.80)
b0.001
Interleukin-6
(pg/mL)
0.75
(0.75–2.43)
1.61
(0.75–3.24)
1.98
(0.75–3.01)
0.107
The values presented are mean ± standard deviation, median (interquartile range) or n
(%). The BMI classes are according to theWHO classiﬁcation for BMI z-score values [27].
BMI, body mass index; WHtR, Waist to height ratio; BP, blood pressure; LDL, low density
lipoprotein; HDL, high density lipoprotein; HOMA-IR— homeostasis model assessment of
insulin resistance.The distribution of PWV levels by obesity indexes (BMI classes and
tertiles of WHtR and body fat mass) is presented in Fig. 1. Considering
BMI classes, compared to normal weight children, the overweight
and obese children presented signiﬁcantly higher levels of PWV
(4.95 (P25–P75: 4.61–5.23), 5.00 (4.71–5.33), 5.10 (4.82–5.50) m/s,
respectively; ptrend b 0.001). Concordantly, higher median PWV
values were found in the highest tertile of WHtR (5.00 (4.60–5.32),
4.97 (4.67–5.20), 5.07 (4.78–5.35) m/s, ptrend = 0.040) and % body
fat mass (4.88 (4.60–5.23), 4.98 (4.68–5.26), 5.13 (4.85–5.45) m/s,
ptrend b 0.001).
The correlations between PWV and CV risk variables is shown in
Table 2. Signiﬁcant positive correlations were found between PWV
and WHtR and body fat mass. Additionally, PWV was positively
correlated with total cholesterol, LDL cholesterol and triglycerides,
with fasting insulin and HOMA-IR levels and with hsCRP. No signiﬁcant
correlation was detected between PWV and z-score values of BP.
In amultivariate linear regressionmodel adjusted for sex, age, height
and 24-h systolic BP (z-score), the independent determinants of PWV
identiﬁed were BMI, HOMA-IR and the absence of dipping pattern
(Table 3). PWV was 0.18 (95% CI: 0.01 to 0.35) m/s higher in the
obese group (compared to the normal weight group), 0.16 (0.03 to
0.28) m/s higher in children without a dipping pattern, and increased
by 0.11 (0.03 to 0.19) m/s per unit of HOMA-IR.
4. Discussion
Carotid-femoral PWV was evaluated in a large sample of healthy
prepubertal children as an indirect marker of arterial stiffness. We
found higher levels of this marker in overweight and obese children,
and also in those with highest WHtR and body fat mass. Moreover,
PWV was signiﬁcantly correlated with several CV risk determinants,
namely blood lipids, insulin and HOMA-IR levels and hs-CRP. In a ﬁnal
multivariate model, BMI, HOMA-IR and the absence of dipping were
independently associated with PWV.
We report a trend for increasing carotid-femoral PWV levels across
BMI classes and other obesity indexes. Several studies reported a greater
arterial stiffness in children with obesity but contradictory results have
been described, with some studies reporting decreased arterial stiffness
[16,17] or increased arterial compliance [29,30] among obese children.
One of these studies that reported lower PWV levels in obese children,
interpreted those ﬁndings as a consequence of overall vasodilatation,
possibly secondary to a physiological adaptation to the highermetabolic
and hemodynamic demands in the obese group [17]. Interestingly,
5 years later, in the same sample, obese children presented higher
PWV levels and a steeper change of arterial stiffness was observed,
with an increase of 25% in PWV levels in the obese group (vs. only
3% in normal weight children) [31]. Moreover, our ﬁndings are in
agreement with the only systematic review and meta-analysis in
children on this topic, that reported greater arterial stiffness in
children with obesity and a consistency between different types
of measures, such as intimae-media thickness and arteries ﬂow-
mediated dilatation [18].
In 2010, reference values for PWVwere published based on a sample
of about 1000 European and northern African healthy children [14].
Although the mean values of carotid-femoral PWV in our sample were
below the 95th percentile of those reference values, we believe that
the observed trends probably translate some degree of early vascular
impairment. Given the expected variations amongpopulations, deﬁning
the most appropriate cut-offs of PWV reference levels for prediction
of CV events requires a longitudinal follow-up of the subjects into
adulthood [14].
Aortic PWV is known to vary during growth. Arterieswidenwith age
and growth, thus causing a natural augmentation in arterial compliance
[32]. It has also been reported that healthy children present stable
values until the age of 8, when a gradual increase in PWV values usually
starts [33]. The process of atherogenesis is believed to begin early in
Fig. 1. Distribution of carotid-femoral pulse wave velocity levels by classes of body mass index (BMI) and tertiles of waist-to-height ratio and percentage of body fat mass. The normal
weight, overweight and obese group classiﬁcation is according to the WHO classiﬁcation for BMI z-score [27]. The tertiles of waist-to-height ratio (≤45.77; 45.77–50.00; N50.00) and %
of body fat mass (≤11.50; 11.50–20.70; N20.70) were deﬁned based on all enrolled participants. The pulse wave velocity data is expressed as medians and percentiles 25 and 75.
P values for linear trend across groups were calculated by linear regression, adjusting for age (in months) and sex.
40 A. Correia-Costa et al. / International Journal of Cardiology 218 (2016) 37–42childhood, with some autopsy studies describing vascular lesions in
children as young as 2 years old [5]. Previous studies have reported
that childhood obesity is associatedwith the development and progres-
sion of atherosclerosis [3]. Thus, we interpret the higher levels of PWV
found in overweight and obese children in our sample of prepubertal
children as evidence that obesity, along with other associated comor-
bidities, is contributing to the acceleration of the age-related process
of atherosclerosis. Several mechanisms have been proposed for the
pathogenesis of vascular damage in the setting of obesity, leading to en-
dothelial dysfunction and loss of its physiologic properties. In children,
studies exploring this topic found obesity-related inﬂammation [34],
oxidative stress [35] and the status of insulin sensitivity [36] to be
associated with markers of arterial stiffness.
One of the most interesting results of our study was the ﬁnding that
PWV levels were independently associated by the absence of dipping.
The loss of the dipping pattern represents an alteration in the circadian
BP variation, in which the physiological decrement of nocturnal BP is
absent, and the prevalence and physiological mechanisms of loss of
dipping BP pattern in children, before the onset of hypertension, areTable 2
Correlations between carotid-femoral pulse wave velocity (PWV) and cardiovascular risk
determinants.
PWV (m/s)
Spearman's correlation p
Age (months) −0.247 b0.001
BMI z-score 0.102 0.070
WHtR (cm/m) 0.132 0.019
% body fat mass 0.207 b0.001
24-h systolic BP (z-score) −0.106 0.062
24-h diastolic BP (z-score) −0.001 0.986
Daytime systolic BP (z-score) −0.089 0.118
Daytime diastolic BP (z-score) −0.009 0.875
Nighttime systolic BP (z-score) −0.100 0.079
Nighttime diastolic BP (z-score) 0.020 0.727
Total cholesterol (mg/dL) 0.166 0.003
LDL cholesterol (mg/dL) 0.160 0.005
HDL cholesterol (mg/dL) 0.064 0.258
Triglycerides (mg/dL) 0.116 0.040
Fasting glucose (mg/dL) 0.030 0.593
Fasting insulin (μIU/mL) 0.125 0.027
HOMA-IR 0.124 0.028
High sensitivity C-reactive protein (mg/L) 0.111 0.048
Interleukin-6 (pg/mL) 0.011 0.841
The values presented are Spearman's ρ and p value.
BMI, body mass index; WHtR, waist to height ratio; BP, blood pressure; LDL, low density
lipoprotein; HDL, high density lipoprotein; HOMA-IR, homeostasis model assessment of
insulin resistance.largely unknown. In adults, it has been reported that the loss of dipping
patternwas associatedwith PWV, in untreated hypertensive adults [37]
and in diabetic patients [38]. Indeed, the non-dipping pattern increases
the risk of BP-related complications and overall mortality [39]. In
children, although ABPM is the recommended method for BP evalua-
tion, being the most strongly related to target organ damage and CV
risk [40], few studies addressed the association of the dipping pattern
with PWV or other arterial stiffness markers and none in healthy
children. A study in type 1 diabetic children found that systolic dipping
was a signiﬁcant predictor of intimae-media thickness [41] and another
study in kidney-transplanted children found that the ambulatory arteri-
al stiffness index, derived from ABPM, was associated with the dipping
state but no associationswere reported betweenPWVandBPor dipping
[42]. Thus,we believe that our novelﬁnding in healthy children expands
the existent evidence in children, and supports the importance of loss of
dipping as an earlymarker of vascular dysfunction and possibly as a sur-
rogate marker of CV risk. In our study, we could not ﬁnd an association
between PWV and z-score BP levels, despite several previous studies
reporting it in children and BP being generally considered a major
determinant of arterial stiffness [6,13,14]. Considering the established
modulating effect of age, height, gender and BP on PWV levels, all
these variables were included in the ﬁnal multivariate model of
carotid-femoral PWV determinants.
We also report an association between PWV and HOMA-IR and,
more importantly, this association held after adjustment for BMI.
Other previous studies reported that children with stiffer vessels
presented higher HOMA-IR levels [22,43,44]. The ﬁnding of HOMA-IR
as an independent determinant of PWV has been described before,
although in an older sample of male adolescents [45]. Furthermore,
insulin resistance before puberty was also shown to be a risk factor forTable 3
Independent determinants of carotid-femoral pulse wave velocity.
Carotid-femoral pulse wave velocity (m/s)
Adjusted β (95% CI) p
BMI classes
Overweight 0.053 (−0.079 to 0.185) 0.427
Obese 0.180 (0.014 to 0.347) 0.034
HOMA-IR (per unit) 0.109 (0.030 to 0.189) 0.007
Absence of dipping (vs. dipping) 0.157 (0.034 to 0.279) 0.012
The values presented are adjusted linear regression coefﬁcients (β) and 95% conﬁdence
intervals, estimated with pulse wave velocity as dependent variable. The adjusted model
is adjusted for all variables in the table and additionally for sex, age (in months), height
(in cm) and 24-h systolic blood pressure (z-score).
BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance.
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of hyperglycemia is believed to induce atherogenesis by increasing
oxidative stress, leading to increased LDL oxidation and decreased nitric
oxide bioavailability, causing endothelial dysfunction [46]. Thus, our
ﬁndings of an early association of PWV and HOMA-IR at such a young
age, along with the existent literature and as suggested by other
authors [44], reinforce the importance of early management of insulin
resistance, as a way to alter future CV risk.
At last, the association between lipids and PWV, although not
holding after full adjustment, is also a relevant ﬁnding. Dyslipidemia is
considered a CV risk factor for atherosclerosis and CV disease in both
children and adults, playing an important role in endothelial injury
and atheromatous plaques development [47]. Although the relation
between lipids disorders and arterial stiffness has been extensively
explored in adults [6], conﬂicting evidence exists concerning this topic
in the pediatric population. Nonetheless, some studies also found a pos-
itive association between PWV and blood lipids [19–21]. Our ﬁndings
support the hypothesis of blood lipids contributing to higher values of
PWV in children and, accordingly, recently published recommendations
for dyslipidemia recommend general screening in children, starting at
9 years of age, in order to identify those at risk for early accelerated
atherosclerosis [48].
4.1. Strengths and limitations
Our study covers an expanding area of investigation and reinforce
that the association between obesity and arterial stiffness is present
even at very young ages. A major strength of our study lies in the fact
that we included a large sample of prepubertal children, homogenous
in terms of age, and with an extensive evaluation of CV risk markers.
As stated above, the study of CV markers in young ages naturally
precludes the establishment of associations with CV events but enabled
us to evaluate the consequences of adiposity on intermediate vascular
phenotypes avoiding indirect and confounding effects that the emer-
gence of target-organ damage and comorbidities might conceal. The
main limitation of our study relates to the cross-sectional design of
our analysis, since only a long-term evaluation of these children could
warrant certainties on the direction and prognostic value of the associ-
ations found. We also have to acknowledge that for PWV analysis some
variability might exist in the determination of length of the carotid-
femoral segment, especially in the setting of obesity when overestima-
tion might occur. Nonetheless, the fact that all measurements were
performed by a single trained cardiopneumology technician helps to
minimize this possible bias and PWV has been accepted as a gold
standard validated method for arterial stiffness measurement, especial-
ly due to its low cost, feasibility and reproducibility, with proved
association with cardiovascular outcomes.
4.2. Conclusions
Our study extends the evidence available on the association of
carotid-femoral PWV with obesity and CV risk factors. The ﬁnding of
an association between this marker of arterial stiffness and the loss
of dipping and insulin resistance levels, independently of the BMI,
reinforces the contribution of obesity-related comorbidities to the
vascular injury in early life. The longitudinal follow-up of high risk
children until adulthood, observing the occurrence of CV events, is
the only way to strengthen the role of PWV as a valid tool for risk
stratiﬁcation and clinical management guidance.
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